STOCK TITAN
  1. Home
  2. Sec-filings
  3. SPRC
  4. [EFFECT] SciSparc Ltd. SEC Filing

[EFFECT] SciSparc Ltd. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT

Rhea-AI Filing Summary

Analyzing...
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: February 12, 2026 9:00 A.M.
Form: F-3
CIK: 0001611746
Company Name: SciSparc Ltd.
File Number: 333-293167

Source: View Original Filing on SEC EDGAR

Scisparc

NASDAQ:SPRC

View SPRC Stock Overview →

SPRC Rankings

#6979 Ranked by Market Cap
N/A Ranked by Dividends

SPRC Latest News

Mar 16, 2026
SciSparc: NeuroThera Labs- Clearmind Medicine Collaboration Leads to Patent Application for Depression Therapy
Mar 12, 2026
SciSparc: NeuroThera Labs Announces Publication of International Patent in Collaboration with Clearmind Medicine for Novel Therapy Targeting Weight Loss and Fatty Liver Disease
Mar 10, 2026
SciSparc: Subsidiary NeuroThera Labs (75%) Signs Definitive Agreement to Acquire Majority Stake in CliniQuantum, Innovator in Quantum-based Clinical trails
Mar 2, 2026
SciSparc Announces 1-for-9 Reverse Share Split
Feb 2, 2026
SciSparc: NeuroThera Labs Granted U.S. Patent for Cannabinoid Technology to Overcome Antimicrobial Resistance such as MRSA

SPRC Latest SEC Filings

Mar 23, 2026
[Form 3] SciSparc Ltd. Initial Statement of Beneficial Ownership
Mar 18, 2026
[Form 3] SciSparc Ltd. Initial Statement of Beneficial Ownership
Mar 18, 2026
[Form 3] SciSparc Ltd. Initial Statement of Beneficial Ownership
Mar 18, 2026
[Form 3] SciSparc Ltd. Initial Statement of Beneficial Ownership
Mar 18, 2026
[Form 3] SciSparc Ltd. Initial Statement of Beneficial Ownership

SPRC Stock Data

2.00M
517.11k
Biotechnology
Healthcare
Link
Israel
Tel Aviv-Yafo